小剂量等比重布比卡因复合舒芬太尼腰硬联合麻醉在剖宫产术中应用价值观察.doc

《小剂量等比重布比卡因复合舒芬太尼腰硬联合麻醉在剖宫产术中应用价值观察.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、小剂量等比重布比卡因复合舒芬太尼腰硬联合麻醉在剖宫产术中应用价值观察［摘要］目的探讨剖宫产术应用小剂量等比重布比卡因复合舒芬太尼腰硬联合麻醉的可行性及安全性。方法选取2014年7月〜2016年2月在我院行剖宫产术的108例产妇为研究对象，经随机数字表法分为观察组54例，对照组54例，对照组给予小剂量等比重布比卡因,观察组在对照组基础上复合应用舒芬太尼。观察两组产妇麻醉效果、生命体征变化及不良反应发生情况。结果观察组运动、感觉阻滞起效时间明显较对照组短，最高感觉平面时间及有效镇痛时间明显较对照组长，差异有统计学意义（P0.05）,麻醉后5、15.30min,观察组心率及平均动脉压与

2、对照组比较差异有统计学意义（P0.05）,两组均未岀现严重不良反应。结论剖宫产腰硬联合麻醉中，选择小剂量等比重布比卡因□秃鲜娣姨□尼可获得满意麻醉效果，产妇生命体征稳定,不良反应少，安全性高，值得推广［关键词］剖宫产；腰硬联合麻醉；布比卡因；舒芬太尼［中图分类号］R614［文献标识码］B［文章编号］1673-9701(2016)34-0112-03Observationoftheapplicationvalueoflowdoseisobaricbupivacainecombinedwithsufentanilinspinal-epiduralanesthesiaincesarea

3、nsectionYUANZongbaoMIAOMinghuiDepartmentofAnesthesiology,WomenandChildren'sHospitalofLiaoning,Shenyang110005,China[Abstract]ObjectiveToinvestigatethefeasibilityandsafetyoflowdoseisobaricbupivacainecombinedwithsufentanilinspinal-epiduralanesthesiainCesareansection.Methods108puerperawhoweregive

4、nCesareansectioninourhospitalfromJuly2014toFebruary2016wereselectedasthestudysubjects.Thepatientsweredividedintotheobservationgroup(54cases)andthecontrolgroup(54cases)accordingtotherandomnumbertable・Thecontrolgroupwasgivenlow-doseisobaricbupivacaine・Theobservationgroupwascombinedwithsufentani

5、lonthebasisofthecontrolgroup.Theanestheticeffect,changesofvitalsignsandadversereactionswereobservedinthetwogroupsofpuerpera.ResultsTheonsettimeofmotorblockandsensoryblockintheobservationgroupwassignificantlyshorterthanthatinthecontrolgroup・Themaximalsensoryplanetimeandeffectiveanalgesiatimewe

6、resignificantlylongerthanthoseinthecontrolgroup,andthediffereneewasstatisticallysignificant(P0.05).At5,15and30minutesafteranesthesia,theheartrateandmeanarterialpressureintheobservationgroupwerestatisticallysignificantlydifferentfromthoseinthecontrolgroup(P0.05).Therewerenosevereadversereactio

7、nsinbothgroups.ConclusionInthecombinedspinal-epiduralanesthesiainCesareansection,satisfactoryresultscanbeobtainedbyselectinglowdoseisobaricbupivacainecombinedwithsufentanil,withstablematernalvitalsigns,lessadversereactions,andhighsafety,which